Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
50.11
-0.59 (-1.16%)
At close: Jun 4, 2025
34.99%
Market Cap 7.54B
Revenue (ttm) 8.39B
Net Income (ttm) 810.95M
Shares Out 148.76M
EPS (ttm) 5.45
PE Ratio 9.30
Forward PE 6.96
Dividend 1.50 (2.96%)
Ex-Dividend Date Apr 22, 2025
Volume 141,938
Average Volume 89,781
Open 50.70
Previous Close 50.70
Day's Range 50.03 - 51.00
52-Week Range 35.06 - 54.70
Beta 0.35
RSI 48.10
Earnings Date May 25, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.